Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.38 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.38 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.38 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 7/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28488195 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL31121686 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL29932678 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259745 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259123 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259494 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL7117447 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1600427 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL1259125 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 | |
| SCHEMBL29610407 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ATDP1LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11786570-B2 | Dermatological product | SYMRISE AG (DE) | 2023-10-17 | — | — | US | claimed |
| CN-118203049-A | Low calorie dessert | DMK德意志牛奶股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-4069904-A1 | FABRIC SPRAYS | Unilever IP Holdings B.V. (NL) | 2022-10-12 | — | — | EP | disclosed |
| EP-4069905-A1 | FABRIC SPRAYS | Unilever IP Holdings B.V. (NL) | 2022-10-12 | — | — | EP | disclosed |
| CN-114727914-A | Product for the indirect transfer of a cosmetic active to the skin | 西姆莱斯股份公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-3947711-A1 | UREA BIOSENSORS AND STABILIZATION OF UREA BIOSENSORS AT ROOM TEMPERATURE | Instrumentation Laboratory Company (US) | 2022-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786570-B2 | Dermatological product | DPM1, FUT5, NAMPT | CYP2C19 1672/4885HIF1A 2993/4885TDP1 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.